Israel’s PolyPid (see here previously) reported positive Phase III trial results on its delayed-release antibiotic treatment applied at the site of surgical infections. The reduction in the risk of infection after surgery was 58% in the 800-patient trial.

https://en.globes.co.il/en/article-polypid-reports-positive-phase-3-surgical-infection-drug-trial-1001512420